Company intelligence / Profile preview

Songhe Immunobiological Medical

Shanghai, Shanghai, China

Ownership: Private
Development stage: Other

Overview

Songhe Immunobiological Medical is a China-based biotechnology company specializing in the development of advanced cell therapies for oncology and autoimmune diseases. The company focuses on engineering immune cells, including CAR-T and NK cell therapies, to target hematological malignancies and solid tumors. Songhe Immunobiological Medical operates research and development facilities in Shanghai, where it advances its pipeline through clinical trials. Their business model encompasses the entire value chain from discovery and preclinical validation to clinical development and potential manufacturing of cell-based biologics.

Therapeutic areas: Oncology
Modalities: Cell therapyBiologicCAR-T cell therapyNK cell therapy
Industry: Biotech

Beyond the preview

Go deeper on Songhe Immunobiological Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Songhe Immunobiological Medical.

Explore the full profile